34
Participants
Start Date
May 3, 2021
Primary Completion Date
June 30, 2025
Study Completion Date
August 31, 2026
Ribociclib
Ribociclib Dose Level 0 (starting dose) 200mg QD Dose Level 1A 400mg QD on Days 8-28 Dose Level 1B 200mg QD Dose Level 2 400mg QD on Days 8-28
Belinostat
"Belinostat Dose Level 0 (starting dose) 600mg/m2 daily for 5 days Dose Level 1A 600mg/m2 daily for 5 days Dose Level 1B 1000mg/m2 daily for 5 days Dose Level 2 1000mg/m2 daily for 5 days~\*Administration on 5 consecutive days is preferred. Administration within 7 days allowed as needed to accommodate holidays and infusion schedules."
RECRUITING
Inova Schar Cancer Institute, Fairfax
RECRUITING
Huntsman Cancer Institute, Salt Lake City
Collaborators (2)
Novartis
INDUSTRY
Acrotech Biopharma
UNKNOWN
University of Utah
OTHER